KeyCorp Issues Positive Forecast for Phreesia (NYSE:PHR) Stock Price

Phreesia (NYSE:PHR - Get Free Report) had its price objective raised by analysts at KeyCorp from $28.00 to $35.00 in a research note issued on Monday,Benzinga reports. The brokerage currently has an "overweight" rating on the stock. KeyCorp's price objective points to a potential upside of 27.38% from the stock's previous close.

PHR has been the topic of a number of other reports. Citigroup restated a "buy" rating on shares of Phreesia in a research report on Wednesday, May 28th. Wall Street Zen raised Phreesia from a "hold" rating to a "buy" rating in a research note on Sunday, June 1st. Canaccord Genuity Group cut their price target on Phreesia from $35.00 to $34.00 and set a "buy" rating on the stock in a report on Thursday, May 29th. Truist Financial lifted their price target on Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a report on Thursday, May 29th. Finally, DA Davidson cut their price objective on Phreesia from $36.00 to $34.00 and set a "buy" rating on the stock in a report on Monday, April 14th. Twelve equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company has a consensus rating of "Buy" and an average target price of $32.27.

Phreesia Stock Performance

NYSE PHR opened at $27.48 on Monday. The business has a 50-day moving average price of $26.34 and a 200-day moving average price of $26.37. Phreesia has a twelve month low of $17.07 and a twelve month high of $30.53. The firm has a market cap of $1.63 billion, a price-to-earnings ratio of -36.47 and a beta of 0.72. The company has a quick ratio of 1.95, a current ratio of 1.95 and a debt-to-equity ratio of 0.02.

Phreesia (NYSE:PHR - Get Free Report) last issued its quarterly earnings data on Wednesday, May 28th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.13) by $0.06. Phreesia had a negative return on equity of 16.23% and a negative net margin of 9.83%. The business had revenue of $115.94 million for the quarter, compared to the consensus estimate of $115.00 million. During the same period in the prior year, the business posted ($0.05) earnings per share. The company's quarterly revenue was up 14.5% compared to the same quarter last year. As a group, equities research analysts predict that Phreesia will post -1.1 EPS for the current fiscal year.

Insider Buying and Selling at Phreesia

In other Phreesia news, SVP David Linetsky sold 23,729 shares of the stock in a transaction that occurred on Friday, June 27th. The stock was sold at an average price of $28.50, for a total transaction of $676,276.50. Following the completion of the transaction, the senior vice president owned 193,510 shares of the company's stock, valued at $5,515,035. This represents a 10.92% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Mark Douglas Smith sold 7,000 shares of the stock in a transaction that occurred on Wednesday, July 2nd. The shares were sold at an average price of $29.00, for a total value of $203,000.00. Following the transaction, the director directly owned 37,353 shares of the company's stock, valued at $1,083,237. The trade was a 15.78% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 54,781 shares of company stock valued at $1,504,911. 5.50% of the stock is owned by insiders.

Institutional Investors Weigh In On Phreesia

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Farther Finance Advisors LLC boosted its holdings in Phreesia by 9,375.0% in the second quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company's stock valued at $86,000 after purchasing an additional 3,000 shares during the period. Diversified Trust Co lifted its holdings in Phreesia by 1.0% during the 2nd quarter. Diversified Trust Co now owns 45,042 shares of the company's stock worth $1,282,000 after buying an additional 426 shares during the last quarter. Moody National Bank Trust Division lifted its holdings in Phreesia by 19.3% during the 2nd quarter. Moody National Bank Trust Division now owns 115,317 shares of the company's stock worth $3,282,000 after buying an additional 18,652 shares during the last quarter. Rhumbline Advisers lifted its holdings in Phreesia by 3.8% during the 1st quarter. Rhumbline Advisers now owns 86,844 shares of the company's stock worth $2,220,000 after buying an additional 3,213 shares during the last quarter. Finally, Strs Ohio purchased a new stake in Phreesia during the 1st quarter worth about $271,000. Institutional investors and hedge funds own 92.10% of the company's stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.